The interaction between different cell-linked proteins has been demonstrated in human cancer cells, and the expression of integrin αvβ5 and claudin-18.2 in cancer tissues showed a significant positive correlation, which could be used to investigate the link between these two potential antibody targets to suggest new targeted therapeutic options. The gene discussed is CLDN18; the disease is cancer.